Results 301 to 310 of about 257,683 (336)
Some of the next articles are maybe not open access.

Clinical Pharmacokinetics of Cyclophosphamide

Clinical Pharmacokinetics, 2005
Cyclophosphamide is an extensively used anticancer and immunosuppressive agent. It is a prodrug undergoing a complicated process of metabolic activation and inactivation. Technical difficulties in the accurate determination of the cyclophosphamide metabolites have long hampered the assessment of the clinical pharmacology of this drug.
Jos H. Beijnen   +3 more
openaire   +4 more sources

Cyclophosphamide in Pregnancy*

Australian and New Zealand Journal of Obstetrics and Gynaecology, 1970
Summary: Cyclophosphamide was given to a young woman with nephrotic syndrome, and was inadvertently continued until the eighth week of her pregnancy. The baby had only two minor malformations; an umbilical hernia and a cutaneous haemangioma, which were probably not due to the cyclophosphamide.
openaire   +3 more sources

Dietary fucoidan of Acaudina molpadioides alters gut microbiota and mitigates intestinal mucosal injury induced by cyclophosphamide.

Food & Function, 2017
Cyclophosphamide (cy) is a widely used cancer drug. Many researchers have focused on the prevention and alleviation of its side effects, particularly damage to the intestinal mucosal barrier.
Hongjie Shi   +7 more
semanticscholar   +1 more source

Synthesis of steroidal cyclophosphamides

Steroids, 1976
The Reformatsky product of estrone methyl ether and ethyl bromo-acetate was transformed by two separate routes to 21-amino-3-methoxy-17alpha-pregna-1,3,5(10)-trien-17beta-ol (9). Cyclization with bis- (2-chloroethyl) phosphoramide dichloride produced the steroidal cyclophosphamide 10.
Emerson L. Foster   +1 more
openaire   +3 more sources

Cyclophosphamide, Cholinesterase and Anaesthesia*

Australian and New Zealand Journal of Medicine, 1972
Summary: A patient receiving cyclophosphamide suffered apnoea and respiratory insufficiency after two anaesthetics in which suxamethonium had been used whilst an anaesthetic without suxamethonium was uneventful; the plasma was found to have a lowered activity of plasma cholinesterase.
P. W. Zapif, IanR. Mackay, I. R. Walker
openaire   +3 more sources

CYCLOPHOSPHAMIDE THERAPY AND STERILITY

The Lancet, 1972
Abstract Fourteen postpubertal male patients who had received cyclophosphamide for 16-500 days provided seminal fluid for analysis. All were azoospermic or oligospermic with or without atypical spermatozoa and reduced motility. The findings support earlier reports that cyclophosphamide therapy consistently produces testicular damage, and suggest that ...
J.H. Pennington   +3 more
openaire   +3 more sources

Cyclophosphamide, DCs, and Tregs

Blood, 2010
Certain chemotherapeutics are now known to augment host immunity by acting on DCs. In this issue of Blood , Nakahara and colleagues demonstrate a unique pharmacologic activity of CTX to selectively eliminate the lymphoid tissue-resident CD8+ DC subset in mice.[1][1] Although chemotherapeutic ...
Akira Takashima, Hironori Matsushima
openaire   +3 more sources

Cyclophosphamide and carcinoma of bladder

Urology, 1978
A case of carcinoma of the bladder developing in a patient who received cyclophosphamide (Cytoxan) therapy for carcinoma of the breast is presented. Hemorrhagic cystitis si a well-documented complication of such therapy. Several recent reports of carcinoma of the bladder in patients receiving cyclophosphamide should make physicians aware of this ...
Gary P. Kearney   +2 more
openaire   +3 more sources

Cyclophosphamide therapy for scleroderma

Current Opinion in Rheumatology, 1998
Pulmonary manifestations are the most common cause of death in patients with scleroderma. Consequently, the importance of treatment of both interstital lung disease and pulmonary hypertension has become increasingly evident. Until a placebo-controlled study of any drug has shown its beneficial effect on pulmonary dysfunction, cyclophosphamide may be ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy